Steven M Kornblau

Steven M Kornblau

UNVERIFIED PROFILE

Are you Steven M Kornblau?   Register this Author

Register author
Steven M Kornblau

Steven M Kornblau

Publications by authors named "Steven M Kornblau"

Are you Steven M Kornblau?   Register this Author

100Publications

3938Reads

40Profile Views

Myeloid malignancies with somatic mutations can be associated with an immunodeficiency phenotype.

Leuk Lymphoma 2019 Aug 16;60(8):2025-2033. Epub 2019 Jan 16.

a Department of Leukemia , The University of Texas MD Anderson Cancer Center , Houston , TX , USA.

View Article

Download full-text PDF

Source
https://www.tandfonline.com/doi/full/10.1080/10428194.2018.1
Publisher Site
http://dx.doi.org/10.1080/10428194.2018.1551535DOI Listing
August 2019

Proteomic Profiling of Acute Promyelocytic Leukemia Identifies Two Protein Signatures Associated with Relapse.

Proteomics Clin Appl 2019 07 4;13(4):e1800133. Epub 2019 Feb 4.

Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030-4009, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/prca.201800133DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6635093PMC
July 2019

Peptide microarray of pediatric acute myeloid leukemia is related to relapse and reveals involvement of DNA damage response and repair.

Oncotarget 2019 Jul 23;10(45):4679-4690. Epub 2019 Jul 23.

Department of Pediatric Oncology/Hematology, Beatrix Children's Hospital, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.27086DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6659796PMC
July 2019

LGALS3 is connected to CD74 in a previously unknown protein network that is associated with poor survival in patients with AML.

EBioMedicine 2019 Jun 16;44:126-137. Epub 2019 May 16.

Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA; Division of Molecular Hematology and Therapy, University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ebiom.2019.05.025DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6604360PMC
June 2019

Antibody Screening.

Adv Exp Med Biol 2019 ;1188:149-163

Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-981-32-9755-5_8DOI Listing
January 2019

Mycoplasma contamination of leukemic cell lines alters protein expression determined by reverse phase protein arrays.

Cytotechnology 2018 Dec 6;70(6):1529-1535. Epub 2018 Sep 6.

Department of Leukemia, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Box 448, Houston, TX, 77030-4009, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10616-018-0244-2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6269355PMC
December 2018

VEGFC Antibody Therapy Drives Differentiation of AML.

Cancer Res 2018 10 5;78(20):5940-5948. Epub 2018 Sep 5.

Division of Pediatric Oncology/Hematology, Department of Pediatrics, Beatrix Children's Hospital, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.

View Article

Download full-text PDF

Source
http://cancerres.aacrjournals.org/lookup/doi/10.1158/0008-54
Publisher Site
http://dx.doi.org/10.1158/0008-5472.CAN-18-0250DOI Listing
October 2018

Mutant NPM1 Maintains the Leukemic State through HOX Expression.

Cancer Cell 2018 09;34(3):499-512.e9

Stem Cell and Regenerative Medicine, Baylor College of Medicine, Houston, TX 77030, USA; Center for Cell and Gene Therapy, Texas Children's Hospital and Houston Methodist Hospital, Baylor College of Medicine, Houston, TX 77030, USA; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA; Department of Pediatrics, Baylor College of Medicine, Houston, TX 77030, USA; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ccell.2018.08.005DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6159911PMC
September 2018

Recurrent Patterns of Protein Expression Signatures in Pediatric Acute Lymphoblastic Leukemia: Recognition and Therapeutic Guidance.

Mol Cancer Res 2018 08 18;16(8):1263-1274. Epub 2018 Apr 18.

Department of Pediatrics, Baylor College of Medicine/Dan L. Duncan Cancer Center and Texas Children's Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1541-7786.MCR-17-0730DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6496939PMC
August 2018

Role of MSC-derived galectin 3 in the AML microenvironment.

Biochim Biophys Acta Mol Cell Res 2018 07 12;1865(7):959-969. Epub 2018 Apr 12.

Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, United States; Section of Molecular Hematology, University of Texas MD Anderson Cancer Center, Houston, TX, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbamcr.2018.04.005DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5936474PMC
July 2018

Shining a light on cell signaling in leukemia through proteomics: relevance for the clinic.

Expert Rev Proteomics 2018 07 6;15(7):613-622. Epub 2018 Jul 6.

d Department of Leukemia , The University of Texas M.D. Anderson Cancer Center , Houston , TX , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14789450.2018.1487781DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6444923PMC
July 2018

Decomposing the Apoptosis Pathway Into Biologically Interpretable Principal Components.

Cancer Inform 2018 9;17:1176935118771082. Epub 2018 May 9.

Department of Biomedical Informatics, The Ohio State University, Columbus, OH, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1176935118771082DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5987987PMC
May 2018

Histone Modification Patterns Using RPPA-Based Profiling Predict Outcome in Acute Myeloid Leukemia Patients.

Proteomics 2018 04 2;18(8):e1700379. Epub 2018 Apr 2.

Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/pmic.201700379
Publisher Site
http://dx.doi.org/10.1002/pmic.201700379DOI Listing
April 2018

Thresher: determining the number of clusters while removing outliers.

BMC Bioinformatics 2018 01 8;19(1). Epub 2018 Jan 8.

Department of Biomedical Informatics, The Ohio State University, 250 Lincoln Tower, 1800 Cannon Drive, Columbus, 43210, OH, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12859-017-1998-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5759208PMC
January 2018

p53 pathway dysfunction in AML: beyond mutations.

Oncotarget 2017 Dec 27;8(65):108288-108289. Epub 2017 Nov 27.

Alfonso Quintás-Cardama: TCR2 Therapeutics, Cambridge, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.22713DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5752443PMC
December 2017

Tumor status and genotype affect the bone marrow microenvironment in acute myeloid leukemia.

Oncotarget 2017 Oct 6;8(48):83354-83369. Epub 2017 Jul 6.

Department of Leukemia, Section of Molecular Hematology and Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.19042DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5663521PMC
October 2017

Low expression of ASH2L protein correlates with a favorable outcome in acute myeloid leukemia.

Leuk Lymphoma 2017 05 13;58(5):1207-1218. Epub 2016 Oct 13.

c Division of Molecular Hematology, Department of Leukemia , The University of Texas MD Anderson Cancer Center , Houston , TX , USA.

View Article

Download full-text PDF

Source
https://www.tandfonline.com/doi/full/10.1080/10428194.2016.1
Publisher Site
http://dx.doi.org/10.1080/10428194.2016.1235272DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5994918PMC
May 2017

Mixed-phenotype acute leukemia (MPAL) exhibits frequent mutations in DNMT3A and activated signaling genes.

Exp Hematol 2016 08 18;44(8):740-4. Epub 2016 May 18.

Cancer and Hematology Centers, Texas Children's Hospital/Baylor College of Medicine, Houston, TX. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.exphem.2016.05.003DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4956537PMC
August 2016

DOT1L as a therapeutic target for the treatment of DNMT3A-mutant acute myeloid leukemia.

Blood 2016 08 22;128(7):971-81. Epub 2016 Jun 22.

Department of Pediatrics, Baylor College of Medicine and Texas Children's Hospital, Houston, TX; Dan L. Duncan Cancer Center, Department of Molecular and Human Genetics, Stem Cells and Regenerative Medicine Center, and Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX;

View Article

Download full-text PDF

Source
http://www.bloodjournal.org/content/bloodjournal/early/2016/
Web Search
http://www.bloodjournal.org/cgi/doi/10.1182/blood-2015-11-68
Publisher Site
http://dx.doi.org/10.1182/blood-2015-11-684225DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4990856PMC
August 2016

Epidermal growth factor receptor is expressed and active in a subset of acute myeloid leukemia.

J Hematol Oncol 2016 08 3;9(1):64. Epub 2016 Aug 3.

Department of Pediatrics, Division of Pediatric Oncology/Hematology, Beatrix Children's Hospital, University Medical Center Groningen, University of Groningen, PO Box 30.001, 9700 RB, Groningen, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13045-016-0294-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4971659PMC
August 2016

The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in Mice.

Authors:
Elizabeth C Townsend Mark A Murakami Alexandra Christodoulou Amanda L Christie Johannes Köster Tiffany A DeSouza Elizabeth A Morgan Scott P Kallgren Huiyun Liu Shuo-Chieh Wu Olivia Plana Joan Montero Kristen E Stevenson Prakash Rao Raga Vadhi Michael Andreeff Philippe Armand Karen K Ballen Patrizia Barzaghi-Rinaudo Sarah Cahill Rachael A Clark Vesselina G Cooke Matthew S Davids Daniel J DeAngelo David M Dorfman Hilary Eaton Benjamin L Ebert Julia Etchin Brant Firestone David C Fisher Arnold S Freedman Ilene A Galinsky Hui Gao Jacqueline S Garcia Francine Garnache-Ottou Timothy A Graubert Alejandro Gutierrez Ensar Halilovic Marian H Harris Zachary T Herbert Steven M Horwitz Giorgio Inghirami Andrew M Intlekofer Moriko Ito Shai Izraeli Eric D Jacobsen Caron A Jacobson Sébastien Jeay Irmela Jeremias Michelle A Kelliher Raphael Koch Marina Konopleva Nadja Kopp Steven M Kornblau Andrew L Kung Thomas S Kupper Nicole R LeBoeuf Ann S LaCasce Emma Lees Loretta S Li A Thomas Look Masato Murakami Markus Muschen Donna Neuberg Samuel Y Ng Oreofe O Odejide Stuart H Orkin Rachel R Paquette Andrew E Place Justine E Roderick Jeremy A Ryan Stephen E Sallan Brent Shoji Lewis B Silverman Robert J Soiffer David P Steensma Kimberly Stegmaier Richard M Stone Jerome Tamburini Aaron R Thorner Paul van Hummelen Martha Wadleigh Marion Wiesmann Andrew P Weng Jens U Wuerthner David A Williams Bruce M Wollison Andrew A Lane Anthony Letai Monica M Bertagnolli Jerome Ritz Myles Brown Henry Long Jon C Aster Margaret A Shipp James D Griffin David M Weinstock

Cancer Cell 2016 07 11;30(1):183. Epub 2016 Jul 11.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ccell.2016.06.008DOI Listing
July 2016

The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in Mice.

Authors:
Elizabeth C Townsend Mark A Murakami Alexandra Christodoulou Amanda L Christie Johannes Köster Tiffany A DeSouza Elizabeth A Morgan Scott P Kallgren Huiyun Liu Shuo-Chieh Wu Olivia Plana Joan Montero Kristen E Stevenson Prakash Rao Raga Vadhi Michael Andreeff Philippe Armand Karen K Ballen Patrizia Barzaghi-Rinaudo Sarah Cahill Rachael A Clark Vesselina G Cooke Matthew S Davids Daniel J DeAngelo David M Dorfman Hilary Eaton Benjamin L Ebert Julia Etchin Brant Firestone David C Fisher Arnold S Freedman Ilene A Galinsky Hui Gao Jacqueline S Garcia Francine Garnache-Ottou Timothy A Graubert Alejandro Gutierrez Ensar Halilovic Marian H Harris Zachary T Herbert Steven M Horwitz Giorgio Inghirami Andrew M Intlekofer Moriko Ito Shai Izraeli Eric D Jacobsen Caron A Jacobson Sébastien Jeay Irmela Jeremias Michelle A Kelliher Raphael Koch Marina Konopleva Nadja Kopp Steven M Kornblau Andrew L Kung Thomas S Kupper Nicole R LeBoeuf Ann S LaCasce Emma Lees Loretta S Li A Thomas Look Masato Murakami Markus Muschen Donna Neuberg Samuel Y Ng Oreofe O Odejide Stuart H Orkin Rachel R Paquette Andrew E Place Justine E Roderick Jeremy A Ryan Stephen E Sallan Brent Shoji Lewis B Silverman Robert J Soiffer David P Steensma Kimberly Stegmaier Richard M Stone Jerome Tamburini Aaron R Thorner Paul van Hummelen Martha Wadleigh Marion Wiesmann Andrew P Weng Jens U Wuerthner David A Williams Bruce M Wollison Andrew A Lane Anthony Letai Monica M Bertagnolli Jerome Ritz Myles Brown Henry Long Jon C Aster Margaret A Shipp James D Griffin David M Weinstock

Cancer Cell 2016 04;29(4):574-586

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, 450 Brookline Avenue, Dana 510B, MA 02215, USA; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ccell.2016.03.008DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5177991PMC
April 2016

Hypomethylation of TET2 Target Genes Identifies a Curable Subset of Acute Myeloid Leukemia.

J Natl Cancer Inst 2015 Nov 13;108(2). Epub 2015 Nov 13.

Fels Institute for Cancer Research and Molecular Biology, Temple University, Philadelphia, PA (JY, JJ, NJMR, MC, JPJI); Department of Leukemia (JY, RT, JJ, NJMR, SAP, SMK, FR, HMK, JPJI) and Department of Hematopathology (CEBR), The University of Texas MD Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djv323DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4862435PMC
November 2015

PKR inhibits the DNA damage response, and is associated with poor survival in AML and accelerated leukemia in NHD13 mice.

Blood 2015 Sep 22;126(13):1585-94. Epub 2015 Jul 22.

Department of Medicine, Division of Hematology and Oncology, Department of Medicine, University of Florida, Gainesville, FL; and University of Florida Health Cancer Center, Gainesville, FL;

View Article

Download full-text PDF

Source
http://www.bloodjournal.org/content/126/13/1585.full.pdf
Web Search
http://www.bloodjournal.org/content/early/2015/07/22/blood-2
Web Search
http://www.bloodjournal.org/cgi/doi/10.1182/blood-2015-03-63
Publisher Site
http://dx.doi.org/10.1182/blood-2015-03-635227DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4582335PMC
September 2015

Progeny Clustering: A Method to Identify Biological Phenotypes.

Sci Rep 2015 Aug 12;5:12894. Epub 2015 Aug 12.

Department of Bioengineering, Rice University.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/srep12894DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4533525PMC
August 2015

Essential role for cyclic-AMP responsive element binding protein 1 (CREB) in the survival of acute lymphoblastic leukemia.

Oncotarget 2015 Jun;6(17):14970-81

Division of Pediatric Oncology/Hematology, Department of Pediatrics, Beatrix Children's Hospital, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4558129PMC
http://dx.doi.org/10.18632/oncotarget.3911DOI Listing
June 2015

Loss of TRIM62 expression is an independent adverse prognostic factor in acute myeloid leukemia.

Clin Lymphoma Myeloma Leuk 2015 Feb 12;15(2):115-127.e15. Epub 2014 Aug 12.

Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2014.07.011DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4560255PMC
February 2015

Age-related changes of healthy bone marrow cell signaling in response to growth factors provide insight into low risk MDS.

Cytometry B Clin Cytom 2014 Nov 16;86(6):383-96. Epub 2013 Sep 16.

Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas M. D. Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cyto.b.21125DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4922007PMC
November 2014

Apoptosis repressor with caspase recruitment domain modulates second mitochondrial-derived activator of caspases mimetic-induced cell death through BIRC2/MAP3K14 signalling in acute myeloid leukaemia.

Br J Haematol 2014 Nov 31;167(3):376-84. Epub 2014 Jul 31.

Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.13054DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4357400PMC
November 2014

The protein phosphatase 2A regulatory subunit B55α is a modulator of signaling and microRNA expression in acute myeloid leukemia cells.

Biochim Biophys Acta 2014 Sep 21;1843(9):1969-77. Epub 2014 May 21.

Division of Molecular Hematology, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Department of Stem Cell Transplantation, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbamcr.2014.05.006DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4165504PMC
September 2014

Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia.

N Engl J Med 2014 Sep;371(11):1005-15

From the Departments of Pathology (K.G.R., D.P.-T., Y.-L.Y., K. McCastlain, G.S., J.M., S.-C.C., J.C., N.S.-M., I.I., J.W., J.R.D., C.G.M.), Computational Biology and Bioinformatics (Y.L., J.B., M.R., E.H., P.G., P.N., G.W., X.C., J.Z.), Biostatistics (D.P., C.C.), Pharmaceutical Sciences (S.W.P., M.V.R., W.E.E.), and Oncology (C.-H.P., S.J.), the Pediatric Cancer Genome Project (Y.L., L.D., C.L., M.R., J.E., J.C., K.B., R.S.F., E.H., P.G., P.N., G.W., X.C., D.Y., B.V., H.M., M.V.R., W.E.E., E.M., R.K.W., J.R.D., J.Z., C.G.M.), and Cytogenetics Shared Resource (M.V.), St. Jude Children's Research Hospital, Memphis, TN; the University of New Mexico Cancer Center and School of Medicine, Albuquerque (R.C.H., I-M.C., C.L.W.); the Genome Institute at Washington University (L.D., C.L., R.S.F., E.M., R.K.W.), the Department of Genetics, Washington University School of Medicine (L.D., C.L., R.S.F., E.M., R.K.W.), and Siteman Cancer Center, Washington University (E.M., R.K.W.) - all in St. Louis; Epidemiology and Health Policy Research, College of Medicine, University of Florida, Gainesville (M.D.); the Research Institute at Nationwide Children's Hospital (S.R., A.S., J.M.G.-F.), the Department of Pathology, College of Medicine, Ohio State University (N.A.H.), and Ohio State University Comprehensive Cancer Center (G.M., C.D.B., K. Mrózek, J.K.) - all in Columbus, OH; the Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas (N.J.W.), Scott and White Hospitals and Clinics and Texas A&M Health Science Center, Temple (G.G.), the University of Texas Health Science Center San Antonio, San Antonio (M.F.-J.), and the Departments of Leukemia and Stem Cell Transplantation, Division of Cancer Medicine, University of Texas M.D. Anderson Cancer Center, Houston (S.M.K., M.K.) - all in Texas; Maine Children's Cancer Program, Scarborough (E.C.L.); New York University Cancer Institute, New York (W.L.C.), and the Department of Medicine (Oncology), Albert Einstein

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1403088DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4191900PMC
September 2014

Preclinical and early clinical evaluation of the oral AKT inhibitor, MK-2206, for the treatment of acute myelogenous leukemia.

Clin Cancer Res 2014 Apr 28;20(8):2226-35. Epub 2014 Feb 28.

Authors' Affiliations: Department of Leukemia; Division of Quantitative Sciences, The University of Texas MD Anderson Cancer Center, Houston, Texas; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington; Division of Hematology/Department of Medicine; Department of Epidemiology, University of Washington, Seattle, Washington; and National Cancer Institute, Rockville, Maryland.

View Article

Download full-text PDF

Source
http://clincancerres.aacrjournals.org/cgi/doi/10.1158/1078-0
Publisher Site
http://dx.doi.org/10.1158/1078-0432.CCR-13-1978DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3989412PMC
April 2014

Design, development, and validation of a high-throughput drug-screening assay for targeting of human leukemia.

Cancer 2014 Feb 25;120(4):589-602. Epub 2013 Oct 25.

David H. Koch Center, The University of Texas MD Anderson Cancer Center, Houston, Texas; Department of Biological and Environmental Sciences, Division of Biochemistry, The University of Helsinki, Helsinki, Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.28419DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4457455PMC
February 2014

Synergistic targeting of AML stem/progenitor cells with IAP antagonist birinapant and demethylating agents.

J Natl Cancer Inst 2014 Feb;106(2):djt440

Affiliations of authors: Section of Molecular Hematology and Therapy, Department of Leukemia (BZC, PYM, DHM, YS, YQ, HM, ROJ, TM, SMK, MA) and Department of Bioinformatics and Computational Biology (HY, KRC), University of Texas M.D. Anderson Cancer Center, Houston, TX; Division of Hematology and Oncology, Mayo Clinic, Scottsdale, AZ (JMB, RT).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djt440DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3952202PMC
February 2014

BH3 profiling discriminates response to cytarabine-based treatment of acute myelogenous leukemia.

Mol Cancer Ther 2013 Dec 3;12(12):2940-9. Epub 2013 Oct 3.

Corresponding Authors: Michael Andreeff, University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 448, Houston, TX 77054.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1535-7163.MCT-13-0692DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3881173PMC
December 2013

Age-related changes of healthy bone marrow cell signaling in response to growth factors provide insight into low risk MDS.

Cytometry B Clin Cytom 2013 Aug 20. Epub 2013 Aug 20.

The University of Texas M. D. Anderson Cancer Center, Department of Stem Cell Transplantation and Cellular Therapy, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cytob.21125DOI Listing
August 2013

Prognostic impact and targeting of CRM1 in acute myeloid leukemia.

Blood 2013 May 5;121(20):4166-74. Epub 2013 Apr 5.

Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2012-08-447581DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3656451PMC
May 2013

Molecular characterization of de novo Philadelphia chromosome-positive acute myeloid leukemia.

Leuk Lymphoma 2013 Jan 9;54(1):138-44. Epub 2012 Jul 9.

Department of Hematopathology, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2012.701739DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3925981PMC
January 2013

The epigenome of AML stem and progenitor cells.

Epigenetics 2013 Jan 18;8(1):92-104. Epub 2012 Dec 18.

Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4161/epi.23243DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3549884PMC
January 2013

Surface Adjustment of Reverse Phase Protein Arrays using Positive Control Spots.

Cancer Inform 2012 11;11:77-86. Epub 2012 Apr 11.

Brigham Young University, Department of Statistics, Provo, UT, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4137/CIN.S9055DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3329188PMC
August 2012

Survivin is highly expressed in CD34(+)38(-) leukemic stem/progenitor cells and predicts poor clinical outcomes in AML.

Blood 2012 Jul 29;120(1):173-80. Epub 2012 May 29.

Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2012-02-409888DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3390955PMC
July 2012

Use of reverse phase protein microarrays to study protein expression in leukemia: technical and methodological lessons learned.

Methods Mol Biol 2011 ;785:141-55

Department of Stem Cell Transplantation, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/978-1-61779-286-1_10
Publisher Site
http://dx.doi.org/10.1007/978-1-61779-286-1_10DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4554538PMC
January 2012

Abnormal expression of FLI1 protein is an adverse prognostic factor in acute myeloid leukemia.

Blood 2011 Nov 13;118(20):5604-12. Epub 2011 Sep 13.

Department of Leukemia, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2011-04-348052DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3217360PMC
November 2011

Up-regulation of homeodomain genes, DLX1 and DLX2, by FLT3 signaling.

Haematologica 2011 Jun 28;96(6):820-8. Epub 2011 Feb 28.

Division of Hematology-Oncology, Medical University of South Carolina, Charleston, SC, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2010.031179DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3105643PMC
June 2011

Evidence of a role for activation of Wnt/beta-catenin signaling in the resistance of plasma cells to lenalidomide.

J Biol Chem 2011 Apr 28;286(13):11009-20. Epub 2010 Dec 28.

Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1074/jbc.M110.180208DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3064156PMC
April 2011

Modeling Protein Expression and Protein Signaling Pathways.

J Am Stat Assoc 2011;107(500):1372-1384

Director of Cancer Research Informatics, North Shore University Health System.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/01621459.2012.706121DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4523312PMC
January 2011